Projects per year
Projects 2019 2024
- 7 Active
Active
Phase 1/1b Study Investigating Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Anti-TIGIT Monoclonal Antibody BGB-A1217 in combination with Anti-PD-1 Monocolonal Antibody Tislelizumab (BGB-A317) in Pateints with Unresectable Locally Advanced or Metastatic Solid Tumors
8/10/19 → 7/10/24
Project: Research
Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma
20/05/19 → 19/05/24
Project: Research
A phase IB open-label, dose-escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with androgen deprivation therapy and other agents in subjects with castrate resistant prostate cancer (CRPC)
4/04/19 → 3/04/24
Project: Research
A Phase 1 study of ES414 in Patients with Metastatic Castration Resistant Prostate Cancer
1/01/19 → 31/12/23
Project: Research